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Abstract
Vitamin D is an essential nutrient and
a secosteroid hormone that regulates
many physiologic processes beyond
calcium and bone homeostasis. These
“extraskeletal” effects are impacted by the
circulating levels of the storage form of
vitamin D, 25-hydroxyvitamin D3. Levels
of vitamin D can be detected after
completing a simple 25(OH)D blood test.
Vitamin D deficiency (<30 ng/mL) is
associated with a higher risk of many
chronic diseases including, but not limited
to, fourteen types of cancers, type 1 and
2 diabetes mellitus, obesity,
cardiovascular disease, hypertension,
stroke, and asthma. This article explores
the association between vitamin D
deficiency and the burden of chronic
diseases in West Virginia.

Introduction
Vitamin D has well-established
roles in calcium and bone
homeostasis. Recently, this necessary
nutrient has been shown to regulate
many other disease and metabolic
processes. These “extraskeletal”
effects of vitamin D include potential
beneficial effects on the prevention
of cancer, obesity, diabetes,
cardiovascular disease, stroke, and
asthma. These diseases burden West

Virginia with significant impact on
morbidity and mortality (Table 1).
Many variables affect these
chronic diseases. West Virginia
leads the nation in the following:
current smokers (25.6%), limitation
in physical activity (27.1%),
insufficient sleep and rest (52.6%),
and self reported poor health
(25.8%).1 West Virginia ranks second
in the nation for obesity (32.5%)
and for percent of population > 65
years of age.1-4 In addition, West
Virginia has one of the lowest
yearly solar irradiance rates in the
country which affects the cutaneous
synthesis of vitamin D (Figure 1). 5
The principal mechanism for
synthesis of the storage form of
vitamin D, a potent fat-soluble
secosteroid hormone, is skin
exposure to sunlight, a mechanism
that is less efficient with increasing

age.6 Cutaneous production of
vitamin D is dramatically altered
by sunblock application (SPF 15;
99% reduction in synthesis) and
seasonal effects due to location
with negligible production from
mid-October to mid-March in West
Virginia (Figure 2).6 Additionally,
an increase in body mass index
(BMI) decreases the bioavailability
of fat-soluble vitamin D with a 1%
increase in BMI associated with a
5% decrease in serum vitamin D
levels.6,7,8 As obesity increases in
West Virginia, so does the risk of
vitamin D deficiency. All of these
factors (inactivity, obesity, location
and age) make the risk of vitamin D
deficiency greater for our population.
The storage form of vitamin D,
25-hydroxyvitamin D3 or 25(OH)
D, can be determined with a simple
blood test with deficiency defined

Table 1. Important WV chronic diseases affected by Vitamin D levels.1
Disease (alphabetical)

Prevalence in WV

Vitamin D
connection

Asthma

8.8%

Yes

Cancer

10.4%

Yes

Diabetes

12.4% (1st highest in US)

Yes

Heart Disease

10.3% (1st highest in US)

Yes

Hypertension

38.4% (2nd highest in US)

Yes

Obesity

32.5% (2nd highest in US)

Yes

Stroke

3.7% (3rd highest in US)

Yes

Objectives
The objective of this article is to explore the association of vitamin D deficiency on major contributors to West Virginia disease
morbidity and mortality.
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as less than 30 ng/mL.11 Vitamin D
deficiency reportedly affects about
50% US adults, with up to 54%
deficiency prevalence noted among
adolescent females.12-15 Because of
increasing evidence linking vitamin
D deficiency with chronic diseases,
diagnosis and prevention beginning
in childhood is paramount.
The purpose of this review article
is to use current data to explore
the association between vitamin
D deficiency and the burden of
chronic diseases in West Virginia.

Normalcy
The human body uses about
3000 to 5000 IU vitamin D3 per
day.16 If cutaneous synthesis is
altered (sunblock, season, age, skin
coloration and disease states), it is
very difficult to obtain this amount
from a non-supplemented diet, even
with a diet rich in fatty wild-caught
fish.6,14,17 Because of this, numerous
health care leaders have proposed
a dramatic increase in the adequate
intake of vitamin D over current
recommendations.18 Many of the
supplementation protocols used in
studies cited in this manuscript have
not accounted for the discrepancy
in total daily use (4000-5000 IU/d)
and recommended adequate
intake (from 200 IU/d to 600IU/d;
dependent on age and pregnancy)
of vitamin D3. We therefore have
placed more emphasis on studies
that have conclusions based on
direct testing of 25(OH)D and its
impact on chronic diseases.

Cancer
The prevalence of cancer in West
Virginians is 10.4%.1 Numerous
studies have shown a correlation
between 14 cancers, including
colorectal, breast, and prostate,
and vitamin D deficiency.19 Data
is inconsistent regarding vitamin
D supplementation and lowered
cancer risk. For example, the

Figure 1.

United States Solar Irradiance Map. The average yearly solar irradiance in Watt/hr is
demonstrated. West Virginia has one of the lowest rates in the contiguous US. Source:
National Renewable Energy Laboratory.3 Available at http://www.nrel.gov/gis/solar.html

Figure 2.

37th Parallel and effect on vitamin D production. West Virginia is above the 37th
parallel resulting in negligible cutaneous production of vitamin D from mid-October
to mid-March. When the leaves are falling, so are 25(OH)D levels. There is a direct
correlation with vitamin D deficiency and distance from the equator.9,10

Women’s Health Initiative showed
supplementing 400 IU of vitamin
D3 combined with 1000 mg
calcium daily to have no effect on
the incidence of colorectal cancer
or breast cancer.20,21 Lappe et al.

showed a significant reduction in
all-cancer risk for women taking
1100 IU of vitamin D3 and 1500 mg
of calcium supplementation.22 The
direction of association is dependent
on sufficient levels of 25(OH)D.
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Cancer risk is decreased when
levels of 25(OH)D are at least 32 ng/
mL.23 Gorham et al., demonstrated
a 50% reduction in colorectal cancer
risk at 33 ng/mL 25(OH)D with a
World Health Organization (WHO)
working group identifying colon
cancer as the greatest risk associated
with poor vitamin D status.24 Garland
et al., showed a 50% reduction in
breast cancer risk at 52 ng/mL
25(OH)D.25 In general, the levels
of circulating 25(OH)D needed to
reduce cancer risk in the population
are much higher than current vitamin
D adequate intake recommendations.

Cardiovascular disease
(CVD), Hypertension, Stroke
West Virginia has the highest
rate of cardiovascular disease in
the US; 10.3% of our population
has symptomatic coronary artery
disease.1 The mechanisms in which
vitamin D may lower cardiovascular
risk have not been fully elucidated,
but many possible mechanisms have
been proposed. For hypertension,
the renin-angiotensin-aldosterone
system (RAAS) appears to be
suppressed by vitamin D with the
risk of hypertension increasing
from south to north in the Northern
hemisphere.26,27 Thus, a deficiency
may lead to hypertension, a risk
factor for CVD. Deficiency of
vitamin D is associated with poor
glycemic control28, another risk
factor for CVD. The presence of
vitamin D decreases inflammatory
markers and even increases antiinflammatory markers, each of which
is beneficial to the cardiovascular
system.29,30 Vascular smooth muscle
and endothelium responds to
vitamin D in a cardioprotective
way by decreasing smooth muscle
cell proliferation31, inflammation16,
and thrombosis.33 Each of these
is a risk factor for cardiovascular
disease. Unfortunately, adequate
clinical trials looking at vitamin D
58   West Virginia Medical Journal

supplementation with cardiovascular
endpoints are lacking. The
Framingham Offspring Study
demonstrated an 80% greater risk
for cardiovascular disease when
vitamin D levels were less than 10
ng/mL compared to participants
with a 25(OH)D level greater than
15 ng/mL.34 Both the Nurse’s Health
Study and the Health Professionals
Follow-up Study found an increased
incidence of hypertension when
25(OH)D levels were below 15 ng/mL
compared to levels above 30 ng/mL.35
A more recent study showed postmenopausal women with 25(OH)D3
levels <20 ng/mL to have increased
cardiovascular risk factors as well as
an increased risk of cardiovascular
disease, cerebrovascular disease,
and death when compared to the
non-deficient (>20 ng/mL 25(OH)
D3) group. Another recent study,
which followed suspected acute
coronary syndrome patients
for 2 years, reported an inverse
relationship with death within that
2 year period and vitamin D status.
Clearly, vitamin D plays a role in the
health of the vascular system, but
research to determine the optimal
level of vitamin D and the role of
supplementation is needed.36
Clinical trials examining the effect
of Vitamin D supplementation on
blood pressure have variable results.
One meta-analysis of 8 clinical trials
demonstrated a significant 3.1 mmHg
reduction in the diastolic pressure
with a non-significant 3.6 mmHg
reduction in systolic pressure when
vitamin D was supplemented.37
Another meta-analysis of 10 trials
found that most did not show
statistically significant effects on
blood pressure.38 Meta-analysis
of trials investigating the effects
of vitamin D supplementation on
cardiovascular outcomes, including
myocardial infarction, stroke, and
other cardiac and cerebral outcomes
showed no statistically significant
effects.38 Trials performed to date,

however, have significant variation
in the vitamin D levels that were
used to define insufficiency,
measured outcomes, doses used,
and identified confounders.38
Multiple studies have
demonstrated an association
between vitamin D insufficiency
and cerebrovascular disease
mortality with one recent study
showing twice the risk of stroke
from lowest (<9.8 ng/mL 25(OH)
D) to highest quartile (>21.5 ng/
mL 25(OH)D).39,40,41 Carrelli et al.
found a correlation between carotid
atherosclerosis, a major risk factor
for stroke, and 25(OH)D status.42 A
population-based study found data
that suggests a reduced intake of
vitamin D in elderly patients, along
with low serum concentrations of
1,25-dihydroxyvitamin D, leads
to an increased risk for future
strokes.43 With numerous studies
revealing an association between
vitamin D status and cerebrovascular
risk, future research should be
directed at determining whether a
causal relationship exists through
clinical supplementation trials.

Asthma
Asthma is a chronic inflammatory
airway disease caused by a
combination of environmental and
genetic factors. In recent years, the
prevalence of children with asthma
was significantly higher in WV than
the nation as a whole. According
to a CDC report based on 2009
data, around 9% of West Virginians
carried a diagnosis of asthma.1
With such a strong prevalence, it
is crucial to continually seek new
methods to treat and reduce the
incidence of this common disease.
Vitamin D receptors are located
in multiple lung cell types and have
beneficial effects on asthma control.
Several mechanisms are used to
promote these effects including
reducing hyperplasia and airway

smooth muscle proliferation,
decreasing inflammation, promoting
lung immunity, slowing cell
cycling, and enhancing the effects of
exogenous steroids.44,45 An inverse
relationship between vitamin D
status and serum IgE levels was
demonstrated by Ma and Zhen.46
This supports the idea that vitamin
D deficiency is related to increased
risk of asthma and allergy.47 A study
by Alyasin et al. in 2011 showed that
serum 25(OH)D levels were inversely
associated with asthma.48 This was a
cross-sectional study conducted with
children and, after adjusting for age,
BMI, and sex, the correlation between
vitamin D and asthma increased.
The study also found a significant
relationship between pulmonary
function test outcomes, such as FEV1
and FEV1/FRC, and vitamin D levels.
Similarly, a case control study by
Ehlayel et al. in 2011 suggested a link
between vitamin D deficiency and
development of asthma and allergic

diseases.49 Vitamin D levels were
lower in asthmatic children than in
control subjects.49 Furthermore, a
Chinese case-control cohort study
revealed that genetic polymorphisms
of vitamin D binding protein increase
the susceptibility of asthma within
the Chinese Han population.50
Searing et al. demonstrated in vitro
that vitamin D can enhance the action
of glucocorticoids on inflammation.51
Thus, correction of vitamin D
deficiency, which is often associated
with asthma, could be a possible
therapeutic option for glucocorticoid
resistant asthma. The exact role
25(OH)D plays on the pathogenesis
of asthma is still under investigation,
but a significant correlation has
been made to higher serum levels of
vitamin D and reduction of asthma.

Diabetes and Metabolic
Syndrome
West Virginia ranks among the
highest in the nation for prevalence

of diabetes with estimates for adults
approximately 12.4%.1 West Virginia
also ranks second nationally for
obesity rates with a prevalence of
32.5%.1 Several studies show an
inverse relationship between BMI
and concentrations of 25(OH)D.7,8
Because vitamin D is fat soluble,
it is readily taken up by fat cells,
and this sequestration of vitamin
D likely plays a large role in its
decreased bioavailability.8 Decreased
levels of 25(OH)D associated with
higher BMI may play a key role in
insulin resistance and thus type-2
diabetes in metabolic syndrome.
Research in this area is relatively
new, and there are some conflicting
findings. One analysis showed
an association between higher
vitamin D concentrations and a
reduced risk for developing type
2 diabetes mellitus in men only.52
Chiu et al. found increased risk for
metabolic syndrome with lower
25(OH)D levels.28 Additionally,
they found that vitamin D is
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directly associated with insulin
sensitivity and release from betacells.28 Unfortunately, randomized
trials investigating the effects of
vitamin D supplementation have
failed to consistently demonstrate a
beneficial effect on insulin resistance
or insulin secretion.53 Most of these
studies were very short in duration
(4 days to 2 years), which may not
be long enough to show clinically
significant beneficial effects.
Vitamin D receptors are present in
activated T and B-lymphocytes and in
activated macrophages, which make
up a portion of our immune response.
Mouse models were used to show
that reduction in the incidence of type
1 diabetes was achieved if the mice
received 1,25(OH)2D3 early in life.54
Of note, the autocrine production of
the locally active form of vitamin D,
1,25(OH)2D3, is critically dependent
on adequate concentration of 25(OH)
D.55 Another study in by Hyppönen
et al. followed a cohort of children
for the first 31 years of life. They
observed that children who received
2000 IU vitamin D during their
first year of life decreased their
risk of developing type 1 diabetes
by 78% compared to children who
did not receive supplementation.56
A meta-analysis by Zipitis and
Akobeng demonstrated significant
reduction in the incidence of type 1
diabetes with supplementation of
vitamin D in the first year of life.57
Follow-up studies are needed to
establish the best treatment regimen
for vitamin D supplementation.

Vitamin D Levels for
Extraskeletal Benefit
Currently, vitamin D intake
recommendations are based solely
on bone health and do not consider
the potential extraskeletal benefits
of higher vitamin D levels. BischoffFerrari et al. suggested target
concentrations of at least 30 ng/mL,
with ideal levels of 25(OH)D around
36-40 ng/mL.58 They also estimated
that to bring half the population to
60   West Virginia Medical Journal

Table 2. Indications for 25(OH)D Testing that may be eligible for Medicare
Reimbursement.55
Disorders of parathyroid gland

Other hyperparathyroidism

Hypoparathyroidism

Rickets, active

Osteomalacia, unspecified

Unspecified vitamin D deficiency

Disorders of phosphorus metabolism

Disorders of calcium metabolism

Chronic kidney disease (CKD)

Secondary hyperparathyroidism
(of renal origin)

Osteoporosis

Other osteoporosis

Disorder of bone and cartilage,
unspecified

Paget’s Disease

History or risk of falls

Fibromyalgia

Malabsorption syndrome

History of bariatric surgery

Liver Disease

Anticonvulsant use

the ideal concentration of 25(OH)D,
daily intake between 700 and 1000
IU of vitamin D would be required.58
Lappe, however, estimated optimal
levels of 25(OH)D to be as low as
30-32 ng/mL.55 Heaney projected that
supplementing the entire population
with 2000 IU/day of vitamin D3
would result in at least 80% of the
population having a 25(OH)D level
greater than 32 ng/mL.59 Daily
intake and production of vitamin D
varies widely with age, BMI, outdoor
activity level, sunblock use, various
disease states (e.g. kidney or liver
disease preventing key hydroxylation
reactions), time of the year, and
latitude.6 The only way to diagnose
and safely treat vitamin D deficiency
is to measure serum 25(OH)D.
Unfortunately, insurance coverage
for measurement is limited.55
Current indications for obtaining
25(OH)D levels are listed in Table 2.
Laboratory testing reimbursement
can occur up to 4 times per annum
with levels determined following
supplementation protocols to
correct vitamin D deficiency.
There are three ways to impact
vitamin D stores: sun exposure, diet

or supplementation. In people with
light skin coloration, sun exposure
below the minimal erythemal dose
(skin redness) is usually enough
to make sufficient daily vitamin
D requirements. This is typically
about 10 minutes during the day
from 10:00 am to 3:00 pm without
sunscreen and with minimal
clothing (i.e. swimsuit).55 However,
at latitudes above 37 degrees North,
from mid-October to mid-March,
no vitamin D is made cutaneously
due to the steep solar angle.55
(Figure 2) Current public sensitivity
connected to sun exposure is worth
noting. Early studies demonstrated
that skin cancer rates increased
with sun exposure, however,
non-skin cancer rates actually
decreased.60,61,62 Additionally, one
should emphasize that many of our
vital processes have an evolutionary
dependence on sun exposure
and vitamin D production (e.g.
immunity) with over 20 photoactive
products produced cutaneously
following sun exposure.6,63 The
ultimate effect of blocking normal
cutaneous photoproduct synthesis
with sunblock is not known.

The second way to alter vitamin D
status is through diet. Many foods are
fortified with vitamin D, and foods
such as wild-caught salmon, tuna,
cod liver oil, and beef liver naturally
contain vitamin D. However,
NHANES III data demonstrate that
diet supplies very little of the 4000 to
5000 IU of vitamin D3 used per day.15
The third way to affect vitamin
D status is supplementation. One
should know that both D2 (plant)
and D3 (animal) are available
over the counter with D3 more
effective in raising 25(OH)D
levels.64,65 We recommend following
current recommendations for
supplementation and testing
protocols as highlighted in the
New England Journal of Medicine.6

Conclusion
Vitamin D receptors are located
in many cell types throughout
the body, and vitamin D plays a
regulatory role in many physiologic
processes. Low levels of the storage
form of vitamin D, 25(OH)D, are
correlated with higher risk of many
diseases including, but not limited to,
asthma, cancer, type 1 and 2 diabetes
mellitus, obesity and metabolic
syndrome, cardiovascular disease,
hypertension, and cerebrovascular
disease. These diseases in particular
have a high prevalence in West
Virginia as well as the U.S. With the
current epidemic of hypovitaminosis
D, it is essential to test for and
correct this modifiable risk factor
by educating patients about
appropriate sun exposure, proper
nutrition, availability, and proper
usage of vitamin D supplements.
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